How should vitamin D deficiency be treated?

Treatment of Vitamin D Deficiency

For confirmed vitamin D deficiency (25(OH)D <20 ng/mL), initiate high-dose repletion with 50,000 IU of vitamin D2 or D3 weekly for 8 weeks, followed by maintenance therapy of 800-2000 IU daily. 1

Treatment Algorithm

Step 1: Determine if Testing is Needed

Measure baseline 25(OH)D levels in patients with:

• Musculoskeletal symptoms (bone pain, proximal muscle weakness, low back pain) 2
• Malabsorption syndromes (celiac disease, inflammatory bowel disease)
• Chronic kidney disease
• Osteoporosis or history of fractures
• Autoimmune diseases
• Cardiovascular disease
• Cancer

Skip testing and proceed directly to empiric supplementation for:

• Dark-skinned or veiled individuals with limited sun exposure 1
• Institutionalized patients 1
• Adults ≥65 years without the above conditions 1
• Pregnant women 3
• Children and adolescents aged 1-18 years 3

Step 2: Repletion Phase (If Deficiency Confirmed)

When 25(OH)D is <20 ng/mL (<50 nmol/L):

Standard repletion regimen:

• 50,000 IU vitamin D2 or D3 once weekly for 8 weeks 1, 2

Alternative rapid correction (if clinically indicated):

• 6,000 IU daily for 4-12 weeks 4

Key principle: Each 1,000 IU daily raises 25(OH)D by approximately 10 ng/mL, though individual responses vary 1

Step 3: Maintenance Phase

After repletion, continue with:

• 800-2000 IU daily of vitamin D3 (preferred) or D2 1, 4, 2
• Target 25(OH)D level: 30-50 ng/mL (75-125 nmol/L) 4

Step 4: Monitoring

• Recheck 25(OH)D after 3 months of supplementation to confirm adequate response 1
• For intermittent dosing regimens, measure just before the next scheduled dose 1
• Increase maintenance dose if levels remain <30 ng/mL despite adherence 1
• In malabsorption syndromes, more frequent monitoring and higher doses may be required 1

Critical Dosing Considerations

Vitamin D3 vs D2

Prefer vitamin D3 (cholecalciferol) over D2 (ergocalciferol) when both are available 1. While daily dosing shows similar efficacy between D2 and D3, vitamin D3 maintains serum levels longer with intermittent dosing regimens 1.

Intermittent vs Daily Dosing

• Daily or weekly dosing is preferred over large intermittent doses 1
• Monthly dosing (e.g., 100,000 IU every 3 months) is acceptable for maintenance 1
• Avoid annual high-dose boluses (e.g., 500,000 IU annually) due to potential adverse outcomes 1

Common Pitfalls to Avoid

Do not routinely screen the general healthy population aged 50-74 years without risk factors 3. The evidence does not support universal testing in this group.

Do not assume all patients respond equally to supplementation. Individual variability in absorption and metabolism means some patients require higher doses, particularly those with:

• Obesity (vitamin D is fat-soluble and sequestered in adipose tissue)
• Malabsorption disorders
• Medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids)

Do not add calcium supplementation routinely. Calcium addition depends on dietary intake; assess individual needs rather than automatically prescribing combination products 1.

Do not monitor calcium levels routinely unless the patient has primary hyperparathyroidism or other calcium metabolism disorders 1.

Special Populations

Pregnant Women

Empiric supplementation is recommended to reduce risks of preeclampsia, preterm birth, and neonatal mortality 3. Standard maintenance doses of 800-2000 IU daily are appropriate.

Adults ≥75 Years

Empiric supplementation is recommended due to potential mortality reduction 3. Use 800-2000 IU daily without necessarily testing baseline levels.

Prediabetes

For high-risk prediabetic patients, supplementation may reduce progression to diabetes 3. Standard maintenance dosing applies.

Practical Implementation

Ensure adherence by:

• Discussing patient preferences for daily vs weekly dosing
• Considering religious or dietary restrictions (vegetarians may prefer D2 from plant sources; some patients avoid alcohol-based preparations) 1
• Explaining that monitoring 25(OH)D levels can improve compliance by demonstrating treatment effectiveness 1

Document the treatment plan clearly: specify the repletion dose, duration, transition to maintenance, and timing of follow-up testing to avoid confusion and ensure completion of the full treatment course.